2.50
InspireMD Inc. stock is traded at $2.50, with a volume of 12,215.
It is down -0.40% in the last 24 hours and down -2.70% over the past month.
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.
See More
Previous Close:
$2.53
Open:
$2.57
24h Volume:
12,215
Relative Volume:
0.22
Market Cap:
$76.60M
Revenue:
$6.21M
Net Income/Loss:
$-19.92M
P/E Ratio:
-2.381
EPS:
-1.05
Net Cash Flow:
$-16.76M
1W Performance:
+15.07%
1M Performance:
-2.70%
6M Performance:
-13.70%
1Y Performance:
-0.79%
InspireMD Inc. Stock (NSPR) Company Profile
Name
InspireMD Inc.
Sector
Industry
Phone
972 3 6917691
Address
4 Menorat Hamaor Street, Tel Aviv
Compare NSPR with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
NSPR
InspireMD Inc.
|
2.50 | 69.24M | 6.21M | -19.92M | -16.76M | -1.05 |
![]()
ABT
Abbott Laboratories
|
133.24 | 235.83B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
106.36 | 157.80B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
384.63 | 150.84B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
81.53 | 111.49B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
76.29 | 45.78B | 5.54B | 4.18B | 623.10M | 7.00 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-07-16 | Initiated | Rodman & Renshaw | Buy |
Mar-13-15 | Downgrade | Oppenheimer | Outperform → Perform |
Nov-26-13 | Initiated | Oppenheimer | Outperform |
InspireMD Inc. Stock (NSPR) Latest News
Inspire Medical Systems (NYSE:INSP) and InspireMD (NYSE:NSPR) Head-To-Head Contrast - Defense World
OrthoPediatrics (NASDAQ:KIDS) versus InspireMD (NYSE:NSPR) Critical Review - Defense World
Piper Sandler Lowers InspireMD (NYSE:NSPR) Price Target to $4.00 - Defense World
InspireMD Inc. Reports Q1 2025 Financial Results - MSN
InspireMD outlines Q3 2025 FDA approval target for CGuard Prime - MSN
InspireMD Inc’s Earnings Call: Growth Amid Challenges - MSN
InspireMD (NSPR) Sees Price Target Reduction by Piper Sandler | - GuruFocus
InspireMD price target lowered to $4 from $4.50 at Piper Sandler - TipRanks
Piper Sandler cuts InspireMD stock price target to $4.00 By Investing.com - Investing.com South Africa
Piper Sandler cuts InspireMD stock price target to $4.00 - Investing.com Australia
InspireMD (NSPR) Price Target Reduced, FDA Approval Timeline Adj - GuruFocus
InspireMD initiated with a Buy at Lake Street - TipRanks
InspireMD, Inc. (NASDAQ:NSPR) Q1 2025 Earnings Call Transcript - Insider Monkey
InspireMD Inc (NSPR) Q1 2025 Earnings Report Preview: What To Lo - GuruFocus
InspireMD Inc (NSPR) Q1 2025 Earnings Call Highlights: Revenue Growth Amid Operational Challenges By GuruFocus - Investing.com Canada
Earnings call transcript: InspireMD Q1 2025 shows mixed results - Investing.com
InspireMD earnings beat by $0.09, revenue fell short of estimates - Investing.com Canada
InspireMD reports Q1 EPS (22c) vs (21c) last year - TipRanks
InspireMD (NSPR) Posts Slight Increase in Q1 Revenue | NSPR Stoc - GuruFocus
InspireMD Inc (NSPR) Q1 2025 Earnings: Revenue of $1.53M Beats E - GuruFocus
InspireMD Stock Dips On Wider-Than-Expected Q1 Loss, But Retail Is Optimistic - NewsBreak: Local News & Alerts
InspireMD Stock Dips On Wider-Than-Expected Q1 Loss, But Retail Is Optimistic By Stocktwits - Investing.com India
InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
InspireMD Reports First Quarter 2025 Financial Results - The Manila Times
InspireMD, Inc. Reports Q1 2025 Financial Results and Anticipates FDA Approval for CGuard™ Prime Carotid Stent System - Nasdaq
Renaissance Technologies LLC Invests $27,000 in InspireMD, Inc. (NYSE:NSPR) - Defense World
INSPIREMD Earnings Results: $NSPR Reports Quarterly Earnings - Nasdaq
INSPIREMD Earnings Preview: Recent $NSPR Insider Trading, Hedge Fund Activity, and More - Nasdaq
InspireMD (NYSE:NSPR) Earns Sell Rating from Analysts at StockNews.com - Defense World
InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference - The Manila Times
InspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.com - Defense World
InspireMD to Announce First Quarter 2025 Financial Results - GlobeNewswire
InspireMD, Inc. to Announce First Quarter 2025 Financial Results on May 9, 2025 - Nasdaq
Destination Excellence: New Clinical Partnerships Inspire MD Students, Aid Community Organizations - Drexel
InspireMD Q1 2025 Earnings: Leading Carotid Stent Developer Reveals Financial Performance Date - Stock Titan
StockNews.com Begins Coverage on InspireMD (NYSE:NSPR) - Defense World
StockNews.com Initiates Coverage on InspireMD (NYSE:NSPR) - Defense World
InspireMD at 24th Annual Needham: Strategic Moves in Healthcare By Investing.com - Investing.com Canada
InspireMD announces inducement grants under Nasdaq listing rule - TipRanks
Inspiremd Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
InspireMD Expands Team: 299K Shares Granted to New Medical Device Experts - Stock Titan
InspireMD files $200M mixed securities shelf - MSN
InspireMD Inc Files For Mixed Shelf Of Up To $200 MillionSEC Filing - MarketScreener
InspireMD Files $200 Million Mixed Shelf - marketscreener.com
InspireMD (NYSE:NSPR) Coverage Initiated at StockNews.com - Defense World
InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference - The Manila Times
InspireMD CEO to Reveal Latest CGuard Strategy at Major Healthcare Conference - Stock Titan
InspireMD (NYSE:NSPR) & AngioDynamics (NASDAQ:ANGO) Head-To-Head Review - Defense World
InspireMD Inc. Stock (NSPR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):